Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bohlen

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Blood|May 26, 1999
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cellsA Jox, T Zander, R Küppers, et al.
British Journal of Haematology|May 3, 2000
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspectsS Titzer, O Christensen, O Manzke, et al.
Gene Therapy|February 1, 1997
Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cellsS Mũcke, A Polack, M Pawlita, et al.
Cancer Research|May 1, 1997
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cellsH Bohlen, O Manzke, S Titzer, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 10, 1996
[Immunotherapy of hemato-oncologic diseases]U Winkler, H Bohlen, V Schirrmacher, et al.
Archives of Biochemistry and Biophysics|May 15, 1993
The skeletal muscle transverse tubular Mg-ATPase: identity with Mg-ATPases of smooth muscle and brainH B Cunningham, P J Yazaki, R C Domingo, et al.
International Journal of Cancer|April 13, 2000
Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectorsS Mücke, A Draube, A Polack, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Blood|January 15, 1994
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxinsU Winkler, C Gottstein, G Schön, et al.
Cytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Blood|May 26, 1999
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cellsA Jox, T Zander, R Küppers, et al.
British Journal of Haematology|May 3, 2000
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspectsS Titzer, O Christensen, O Manzke, et al.
Gene Therapy|February 1, 1997
Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cellsS Mũcke, A Polack, M Pawlita, et al.
Cancer Research|May 1, 1997
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cellsH Bohlen, O Manzke, S Titzer, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 10, 1996
[Immunotherapy of hemato-oncologic diseases]U Winkler, H Bohlen, V Schirrmacher, et al.
Archives of Biochemistry and Biophysics|May 15, 1993
The skeletal muscle transverse tubular Mg-ATPase: identity with Mg-ATPases of smooth muscle and brainH B Cunningham, P J Yazaki, R C Domingo, et al.
International Journal of Cancer|April 13, 2000
Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectorsS Mücke, A Draube, A Polack, et al.
International Journal of Cancer|July 9, 1993
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphomaC Pohl, R Denfeld, C Renner, et al.
Blood|January 15, 1994
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxinsU Winkler, C Gottstein, G Schön, et al.
Cytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.
Pageof 7